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Effe-cts of Glucocorticoids on the Beta-Adrenergic Adenylate Cyclase 
System of Pig Skin 
HAJIME liZUKA, M .D., PH.D., AND AKIRA 0HKAWARA, M.D., PH.D. 
Department of Dermatology, A sahihawa M edical College, Asahihawa, Japan. 
Effects of glucocorticoids on the epidermal beta-adre-
nergic adenylate cyclase system were investigated. 
Long-term incubation of pig skin slices in RPMI 1640 
medium resulted in the gradual decrease in the epineph-
rine-induced cyclic AMP accumulations of skin. The ad-
dition of hydrocortisone (100 J.tM) in the incubation me-
dium prevented this decrease, and after 24- and 48-h 
incubation, there was a marked difference in beta-adre-
nergic responsiveness between control and hydrocorti-
sone-treated skin. The study using other steroid hor-
mones revealed that this effect on the beta-adrenergic 
system was relatively specific for glucocorticoids. Hy-
drocortisone, prednisolone, dexamethasone, and beta-
methasone-17-valerate were shown to have marked ef-
fects on the beta-adrenergic system, while androstene-
dione, testosterone, dihydrotestosterone, progesterone, 
estrone, and beta-estradiol had no effect. Cortisone and 
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estriol were shown to have similar but weaker effects 
than hydrocortisone. The effect of glucocorticoids was 
also relatively specific to the beta-adrenergic system, 
since there was no significant difference in adenosine-
or histamine-induced cyclic AMP accumulations of skin 
after long-term incubation with and without hydrocor-
tisone. 
The mechanism of this glucocorticoid action does not 
seem to be through the simple protection of the beta-
adrenergic system of the skin, since the addition of hy-
drocortisone in the incubation medium at 24 or 48 h 
incubation time, when the epinephrine-induced cyclic 
AMP accumulation was considerably decreased, re-
versed the epinephrine unresponsiveness of the skin, 
after the additional 24-h incubation. Furthermore, the 
effect of hydrocortisone was inhibited by 3 different 
kinds of inhibitors : (a) progesterone, an inhibitor of 
intracytoplasmic glucocorticoid receptor binding; (b) ac-
tinomycin D, an inhibitor of messenger RNA (mRNA) 
synthesis; and (c) cycloheximide, an inhibitor of protein 
synthesis at the translation step. 
These results are in accordance with the view that 
glucocorticoids affect the beta-adrenergic system of ep-
idermis by a mechanism requiring mRNA and protein 
synthesis possibly through the intracytoplasmic gluco-
corticoid receptor system of epidermis. 
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The role of receptors of the adenylate cyclase [ATP pyro-
phosphate-lyase (cyclizing) ; EC 4.6.1. 1] system in mediating t h e 
effects of hormones and ch emicals on target cells is well estab-
lished [1,2). With th e exception of th e soluble rat testicular 
enzyme [3], adenylate cyclase is a membrane-bound enzyme 
complex, and located at t he outer cell membrane surface is th e 
receptor component containing a specific s ite for binding of 
hormones and ch emicals, which then initiates a train of events 
leading to th e activation of adenylate cyclase (catalytic com -
ponen t) and to th e formation of cyclic AMP. Previous data 
from our and other laboratories establish ed t hat mammalian 
epidermis contains at least 4 independent receptor adenylate 
cyclase systems which respond respectively to catecholamines 
(beta-adrenergic agonists), to the prostaglandins (E1 and E 2), to 
histamine (H2 agonists), and to adenosine and its phosphoryl-
ated derivatives, resulting in the accumulation of cyclic AMP 
[4-6). 
Among these 4 independent receptor adenylate cyclase sys-
tems in epidermis, th e beta-adrenergic system h as been char-
acterized by its unstable or vulnerable nature, and epinephrine 
responsiven ess of epidermis was sh own to be easily lost by 
several in vivo or in vitro m a nipulations [7-9). Defective beta-
adren ergic responsiveness h as also been noted in several path-
ologic conditions of epidermis [6,10). 
Previously we have reported th at th e long-term incubation 
of pig skin (epiderm al) slices resulted in a gr adual decrease in 
beta-adrenergic responsiveness of the skin and furthermore 
that h y drocortisone h ad apparently a protective effect on this 
beta-adrenergic system without a significan t effect on cyclic 
AMP phosphodiesterase activit ies [ll). This observation was 
followed by the finding that pretreatment of the skin with 
hydrocortisone magnified the inhibitory effect of epinephrine 
on e pidermal outgrowth a nd mitosis [12], suggesting that hy-
drocortisone might r eveal its physiologic and/ or pharmacologic 
effect through th e protective effect on the beta-adrenergic 
adenylate cyclase system of epidermis. 
Using t h e long-term incubation system , om- study was under-
taken to clarify the natm-e a nd the m echanism of this hydro-
cortisone effect on the beta-adrenergic adenylate cyclase system 
of epidermis. Through this study we have confirmed the pre-
vious finding of hydrocortisone effect on the beta-adrenergic 
system , and, using various steroids, we establish ed t he specific-
ity of this glucocorticoid effect. The evidence that this gluco-
corticoid effect is not through th e simple protection of the beta-
adren ergic system but seems to be manifested through t he 
glucocorticoid receptor-induced active protein synthesis process 
was also presented. 
MATERIALS AND METHODS 
Domestic pigs weighing about 10 kg were anesthesized with nembutal 
(Dainippon, Osaka, Japan) i.p. (dose 30 mg/ kg) , as previously described 
[13]. Fifteen minutes after the anesthesia, skin slices were taken from 
the backs of pigs using a Castroviejo keratome (Storz Instrument Co. 
St. Louis, Missouri) . Keratome shims were selected to give an average 
thickness of 0.2 mm and the skin slices thus obtained were histologically 
ch ecked and were confirmed to be predominantly epidermis (- 80%). 
The skin slice was cut into 5 X 5 mm squares, washed 3 times in RPMI 
1640 medium, and floated with their keratin layers up in 10 ml ofRPMI 
1640 medium wi th added antibiotics (100 units/ ml penicillin, 0.1 mg/ 
ml streptomycin, 0.25 llg/ ml fungizone) and various steroids to be 
tested. The incubations were done essentially according to the method 
of Flaxman and Hru·per [14) at 37°C in an atmosphere of 5% C02 in air. 
Since serum contains an unknown amount of growth factors which 
include glucocorticoids, serum was not added in the incubation medium. 
Under these conditions using chemically defined medium, epidermis 
was well maintained for up to at least 72 h [11,14]. Steroids were 
dissolved in ethanol and the final concentration of ethanol was 0.5% v/ 
v. As control, only ethanol was added to the medium. As previously 
described [11], ethanol had no effect on the cyclic AMP levels of the 
skin at this concentration. After an appropriate time, the skin squares 
were transferred and floated in new RPMI 1640 medium at 37°C for 
cyclic AMP accu mulation studies. Skin squares were preincubated at 
37°C for 15 min to standardize the cyclic AMP level and after the 
prein cubation 2 squares were randomly selected and floated in RPMI 
1640 medium containing the various chemicals to be tested. The con-
centrations of epinephrine, histamine, and adenosine added for the 
cyclic AMP accumulation were 50 /lM, 1 mM, and 2 mM, respectively. 
Previously it was shown that the concentrations of these chemicals 
were sufficient for the maximal accumulation of cyclic AMP, which was 
atta ined after 5 min without cyclic AMP phosphodiesterase inhibitors 
(15-17]. After the incubation at 37°C in a water bath (for 5 min unless 
otherwise stated), skin squru·es were quickly frozen between 2 plates of 
dry ice. The cyclic AMP content in these skin squares was measw-ed 
by radioimmunoassay using a Yamasa cyclic AMP assay kit (Yamasa 
Shoyu Co. Tokyo, Japan) after partial purification by the method of 
Yoshikawa et al (18]. 
Protein concentration was measured by the method of Lowry et al 
[19]. Chemicals and drugs were all prepared fresh before each experi-
ment and the pH of the medium was adjusted to 7. T he statistical 
significance was determined by Student's t-test except that no statistical 
significance is indicated in any of the tables or figmes. 
RPMI 1640 medium was purchased from GIBCO (Grand Island, 
New York) . Epinephrine was the product of Dai.ichi Pharmaceutical 
Co. (Tokyo, Japan) . Penicillin-streptomycin-fungizone mixture was ob-
tained from M.A. Bioproducts (Walkersville, Mru·yland). Progesterone 
was from Merck & Co. Inc. (Rahway, New J ersey), testosterone from 
Mann Research Labs Inc. (New York, New York) , dihydrotestosterone 
from Teikoku Zoki Co. (Tokyo), and estrone from Nakarai Chemicals 
Ltd, (Kyoto, Japan). Betamethasone-17-valerate was a generous gift 
fro m Shionogi Phru·maceutical Co. (Osaka, Japan). Actinomycin D and 
cycloheximide were from P-L Biochemical Inc. (Milwaukee, Wisconsin) 
and Boehringer Mannheim Gmbh (FRG), respectively. AU other chem-
icals were obtained from Sigma Chemical Co. (St. Louis). 
RESULTS 
Fig 1 shows the t ime cow-se of the effect of hydrocortisone 
on th e beta-adrenergic adenylate cyclase system of the skin. 
When pig skin squares were incubated without hydrocor tisone, 
the epinephrine-induced cyclic AMP accumulations of skin 
gradually decreased. The addi t ion of hydrocortisone in the 
incubation m edium prevented the decrease or even increased 
the beta-adrenergic responsiveness, and after 24 and 48 h in-
cubation time, there was a marked differen ce in epinephrine 
responsiveness between control and hydrocortisone-treated 
skin. In these experiments, usually at least 6 h incubation tin1e 
was required for the detection of th e difference and, during the 
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FIG l. Effect of hydrocortisone on the beta-ac:U-energic adenylate 
cyclase system of pig epidermis. Skin squares were incubated in HPMI 
1640 medium for an appropriate time with (e-e) and without (0 -
0 ) hydrocortisone. At the indicated time, epinephrine-stimulated cyclic 
AMP was measmed after 5-min incubation with 50 llM epinephrine. 
Cyclic AMP level at 0 h indicates the epinephrine-stimulated cyclic 
AMP value of the skin without long-term incubation. Hydrocortisone 
was dissolved in ethanol and the final concentration of each chemical 
was 100 llM and 0.5% (v / v) respectively. Resul ts are the means± SE 
(n = 4). 
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first 3 h of incubation, there was no difference in epinephrine 
responsiveness between control and h ydrocortisone-treated 
skin (data not shown). No histologic difference was noted 
between control and hydrocortisone-treated skin during the 
long-term incubation period and epidermal architecture was 
well maintained for up to 72 h (figure not shown). 
That this effect of hydrocortisone is relatively specific to the 
beta-adrenergic system is shown in Fig 2. In contrast to the 
epinephrine responsivenesses, adenosine- and histamine-in-
duced cyclic AMP accumulations of the skin gradually in-
creased during the long-term incubation period. The addition 
of hydrocortisone in the incubation medium had no effect on 
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FIG 2. Effect of hydrocortisone on the adenosine and histamine (H2) 
receptor adenylate cyclase systems of pig epidermis. Skin squares were 
incubated in RPM! 1640 medium exactly in the same way as in Fig 1. 
At the indicated time, adenosine- and histamine-stimulated cyclic AMP 
were measured after 5-min incubation with each chemical (adenosine, 
2 mM; histamine, 1 mM). Results are the means ± SE (n = 4). 0 - 0 = 
Adenosine response of the control skin; • - • = adenosine response of 
the hydrocortisone-treated skin; 6 - 6 = histamine response of the 
control skin; .i.-.i. = histamine response of the hydrocortisone-treated 
skin. 
TABLE I. Steroid sp ecificity in the modulation of beta· adrenergic 
adenylate cyclase responsiveness 
Experimental series 1 
Control 
Cortisone 
Hydrocortisone 
Prednisolone 
Dexamethasone 
Betamethasone-17 -valerate 
Experimental series 2 
Control 
Anru·ostenedione 
Testosterone 
Dihyru·otestosterone 
Hyru·ocortisone 
Experimental series 3 
Cyclic AMP (pmol/ mg protein) 
No addi tion 
0.7 ± 0.1 
0.9 ± 0.2 
1.1 ± 0.2 
1.1 ± 0.2 
0.9 ± 0.1 
0.8 ± 0.1 
0.8 ± 0.1 
0.8 ± 0.1 
0.9 ± 0.1 
1.1 ± 0.1 
1.1 ± 0.1 
Epinephrine 
4.6 ± 0.6 
14.3 ± 1.2 
22.4 ± 2.6 
25.4 ± 4.6 
20.1 ± 2.2 
23.3 ± 2.2 
4.9 ± 0.2 
5.4 ± 0.9 
4.6 ± 0.4 
6.8 ± 1.3 
21.5 ± 1.2 
Control 1.2 ± 0.2 4.1 ± 0.5 
Estrone 1.5 ± 0.2 4.4 ± 0.5 
Estradiol 1.5 ± 0.3 6.9 ± 0.8 
Estriol 1.4 ± 0.2 13.1 ± 1.9 
Progesterone 0.7 ± 0.2 2.7 ± 0.2 
Hyru·ocortisone 1.0 ± 0.2 30.5 ± 3.4 
Skin squares were incubated in RPM! 1640 medium with various 
steroid hormones. After 48-h incubation, skin squares were incubated 
with 50 p.M epinephr ine for 5 min. No phosphodiesterase inhibitor was 
added in the media. Each steroid hormone was dissolved in ethanol 
and the fin al concentrations were 100 p.M and 0.5%. Results are the 
means ± SE (n = 4). 
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TABLE II. Effects of various inhibitors of g lucocorticoid action 
Cyclic AMP pmol/ mg protein 
No addition E pinephrine 
Experimental series 1 
Control 1.0 ± 0.1 5.2 ± 0.5 
Progesterone (100 p.M) 0.5 ± 0.1 2.5 ± 0.2 
Hyru·ocortisone (100 p.M) 0.8 ± 0.1 25.9 ± 7.5 
Hydrocortisone (100 p.M) 
+ progesterone (1 p.M) 0.9 ± 0.2 28.6 ± 6.8 
+ progesterone (10 p.M) 1.1 ± 0.2 20.2 ± 5.2 
+ progesterone (50 fJ.M) 0.7 ± 0.1 12.2 ± 1.8 
+ progesterone (100 p.M) 0.5 ± 0.1 3.0 ± 0.4 
Experimental series 2 
Control 1.6 ± 0.2 8.4 ± 1.7 
Actinomycin D (5 p.g/ml) 1.3 ± 0.3 7.0 ± 0.8 
Hydrocortisone (100 p.M) 1.7 ± 0.3 21.2 ± 3.8 
Both agents 1.5 ± 0.2 10.2 ± 0.8 
Experimental series 3 
Control 1.1 ± 0.2 4.5 ± 0.6 
Cycloheximide (0.5 p.M) 1.2 ± 0.3 5.2 ± 0.3 
Hydrocortisone (100 p.M) 1.1 ± 0.1 21.0 ±6.0 
Both agents 1.2 ± 0.2 8.7 ± 0.4 
Skin squares were incubated in RPMI 1640 medium with various 
chemicals. After 48-h incubation, skin squares were incubated wi th 50 
p.M epinephrine for 5 min. Results are the means± SE (n = 4). 
adenosine- or histamine-induced cyclic AMP accumulations. 
Because of the weak response of the epidermal prostaglandin E 
adenylate cyclase system [5], the effect of hydrocortisone on 
this receptor system was not determined in the present study. 
The effect of various steroids on the be ta-adrenergic respon-
siveness of the skin is shown in Table I. Since the effect of 
hydrocortisone on beta-adrenergic responsiveness was consid-
erably varied from experiment to experiment, the results of 3 
typical experim ental series are shown. In each series, the data 
of hydrocortisone-treated skin were included as a positive con-
trol in order to show a reliable estimation of the effect of each 
steroid. Glucocorticoids such as hydrocortisor:e, prednisolone, 
dexamethasone, and betamethasone-17-valerate were shown to 
have marked effects on the beta-adrenergic system of the skin 
and there was no difference in potency among the steroids at 
the concentrat ion used (100 Jl.M each). Androstenedione, testos-
terone, dihydrotestosterone, estrone, beta-estradiol, and pro-
gesterone h ad no effect on beta-adrenergic responsiveness. Cor-
tisone and estriol were shown to have moderate effects. 
The effects of progesterone, actinomycin D, and cyclohexi-
mide on the hydrocortisone effect are shown in Table II. Skin 
squares were incubated with hydrocortisone and/or various 
inhibitors, and epinephrine-induced cyclic AMP accumulations 
were investigated. When progesterone was added in the incu-
bation medium, there was a marked inhibition of h ydrocorti-
sone effect. This inhibitory effect of progesterone was roughly 
dose dependent and at 100 J1.M concentration almost complete 
inhibition of hydrocortisone effec t was observed. At I Jl.M con-
centration, progesterone had no effect. Effect of hydrocortisone 
was also inhibited by the addition of 5 }lg/ ml actinomycin D, an 
inhibitor of transcription (mRNA synthesis) and by 0.5 Jl.M 
cycloheximide, an inhibitor of protein synthesis at the transla-
tion step. There was no differ ence in epinephrine responsiveness 
between control and actinomycin D -treated skin (Table II, 
series 2) or cycloheximide-treated skin (Table II, series 3) at 
the concentrations used. 
Fig 3 shows the reversal of epinephrine unresponsiveness by 
the addition of hydrocortisone. Hydrocortisone was added in 
the incubation medium at the indicated times (24 and 48 h) , 
when the epinephrine responsiveness was considerably de-
creased (see also Fig 1). It was shown that the addit ion of 
hydrocortisone markedly increased the epinephrine responsive-
ness, and after each additional 24 h incubation time there was 
a marked difference in epinephrine responsiveness between 
control and hydrocortisone-treated skin . The epinephrine re-
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FIG 3. Reversal of epinephrine unresponsiveness by hydrocortisone. 
S kin squares were incubated in RPMI 1640 medium for the fu·st 24 and 
48 h without the addition of hydrocortisone. At the indicated time (24 
and 48 h) skin squares were divided into groups and each group was 
incubated fo r the additional 24 h in a new RPMI 1640 mediu m with 
(e ) and without (0 ) hydrocortisone. One group was incubated with 100 
J.LM h ych ocortisone plus 0.5 !LM cycloheximide (6) at the 24-h incubation 
t ime. Epinephrine-stimulated cyclic AMP was measured at the indi-
cated time as in Fig 1. Results are the means± SE (n = 4). 
sponse of t he hydrocort isone-t reated skin was shown to be more 
t h a n the original response of t he skin without the long-term 
incubation in some occasions as in this figm e. This effect of 
h y drocor t isone was also inhibited by the simultaneous addi t ion 
of 0.5 J.LM cycloheximide (Fig 3, l:. ). 
DISCUSSION 
Our data indicate that hydmcor tisone relatively specifically 
works on the beta-adrenergic adenylate cyclase system in epi-
dermis. Although t here was a marked difference in epinephrine-
induced cyclic AMP accumulations after long-term incubation 
with and without hydrocort isone (Fig 1) , no difference in aden-
osine- or histamine-induced cyclic AMP accumulations was 
noted (Fig 2). Fwt hermore, in con trast to epinepluine respon-. 
siveness of the control skin, both adenosine a nd histamine 
responsivenesses gradually increased dw·ing t he long-term in-
cubation period (Fig 2). Previously we have reported that both 
lo w and high K, cyclic AMP phosphodies terase activities de-
creased during the long-term incubation period [11]. At 48 h 
incubation time, the low and high K, phosphodiesterase activ-
ities were 78% a nd 66% of the original activit ies, respectively 
[ 11]. Since, in our system, incubations for cyclic AMP accu-
m ulations were carried out withou t the addi t ion of phosphodi-
esterase inhibitors, the decreased phosphodiesterase activi t ies 
migh t r esult in the apparent increase in adenosine- and hista-
mine-induced cyclic AMP accumulation. Gradual decrease in 
epinephr ine-induced cyclic AMP accumulations of the control 
skin despite the decreased phosphodiesterase activi ties, t here-
fore, further strength ens th e fact that the beta-adrenergic sys-
tem is quite an unstable receptor system in epidermis. 
The effect on the beta-adrenergic system was also specific to 
glucocor ticoids. All the glucocor ticoids, hydrocort isone, pred-
nisolone, dexamethasone, and betamethasone-17 -valerate were 
sh own to have ma1·ked effects on the beta-adrenergic system of 
epidermis (Ta ble I). Al though there were no differences in 
potency among these steroids at the concentrations used (100 
J.LM each), our recent observation suggests that potent glucocor-
t icoids such as betamethasone-17 -valerate reveal their effects 
with much lower concentrations than hydrocortisone [20]. Us-
ing the long-term incubation system, we are currently investi-
gating the effect of various concentrations of steroids to estab-
lish the glucocor ticoidal potency among them. Androgens (an-
grostenedione, testosterone, and dihydrotestosterone), estro-
gens (estrone and beta-estradiol), and progesterone had no 
effect on the beta-adrenergic system of epidermis. Cortisone 
and estriol were shown to have moderate effects (Table I). 
Cort isone, which in itself is a biologically inactive glucocorticoid 
[21], migh t be metabolized and reveal its effect as hydmcorti-
sone, a finding observed in several other t issues [22,23]. 
There are several possibilities concerning t he m echanism of 
this glucocorticoid effect. Lysosomal membrane stabilization 
has been proposed for some t ime as a mechanism for th e a nti-
inflammatory effect of glucocorticoids [24,25]. Lysosom es con-
tain digestive enzymes including proteases, nucleases, phospha-
tases, etc. Since previous data from om laboratory sh owed that 
the beta-adrenergic system was t he most sensit ive receptor 
system in epidermis to protease treatment [7], and since hydr o-
cortisone apparently protected a nd preserved the beta-adrener -
gic responsiveness after a long-term incubation period, we for-
merly proposed this mechanism as the possible hydrocortisone 
effect [11]. Om present study, however, is contradictory to the 
simple protection mecha nism. The effect of hydrocortisone was 
inhibited by protein synthesis inhibitors (T able II). T he addi-
t ion of hydrocortisone in th e incubation medium at 24 and 48 
h incubation t ime markedly increased the epinephrine respon-
sivenesses of the skin almost to or more than the init ial response 
of the skin (Fig 3). Al though hydrocor tisone stabilizes lysosom al 
membrane of the liver as was originally described by de D uve 
et al [24], recent studies using various other cell systems have 
failed to document the effect of hydrocortisone, and the stabi-
lization hypothesis has been challenged [26]. 
Another possibility is that glucocorticoid reveals its effect 
through the .classical steroid re~e~tor p.athway. According to 
the current v1ew of the glucocor ticOid actiOn [27], in target cells 
glucocor t icoids bind to specific cytoplasmic recep tor protei~ 
which becom es activated and t ranslocates into nuclei. T here 
this hormone-recep tor complex interacts with chrom atin, l ead~ 
ing to specific mRN A and consequent specific protein syn t hesis, 
eventually resul ting in the observed phenotypic responses of 
target cells. In epidermis the existence of t he glucocorticoid 
receptor system was established just recen tly [28- 30] a nd it is 
qui te likely that the effect of glucocort icoids on the beta-adre-
nergic system is tluough this steroid receptor system . Consist-
ent with the time-consuming protein synthesis process, it re-
quired more than a 6-h lag period to detect the effect of 
glucocorticoid (Fig 1) . T he effect of glucocorticoid was in hi bited 
by differe nt kinds of inhibitors which work at 3 distinct sites of 
the glucocorticoid receptor pathway (T able II, Fig 3). P roges-
terone has been known to bind to intracytoplasmic glucocort i-
coid receptor and reveal its antiglucocort icoidal activity [31, 
32]. Actinomycin D and cycloheximide are the classical inhibi-
tors of protein synthesis at the transcription and tra nslation 
step, respectively. Although not conclusive, these findings sug-
gest that glucocorticoid reveals its effect t hrough t he specific 
protein synthesis process and t his specific protein in tuTn seems 
to regulate t he beta-adrenergic adenylate cyclase system of 
epidermis. Consistent with our finding, t here are several other 
systems in which glucocorticoids induce the expression of var-
ious components of the beta-adrenergic adenylate cyclase sys-
tem [33- 36]. 
It should be noted that 100 J.L M hydrocortisone is a concentra-
t ion far higher than is needed to saturate glucocorticoid recep-
tors in vit ro in cell-free systems [28- 30]. Previously we repor ted 
that no effect was observed at 0.1 J.LM hydrocortisone [11]. which 
is apparent ly more t han enough for the saturation of epidermal 
glucocor ticoid receptors in vitro (28]. Furthermore, t he inh ibi-
tory effect of progesterone on the glucocor t icoid effect (Table 
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II) was stronger than our expected value. Since progesterone 
binds less well to epidermal glucocorticoid receptors than hy-
drocortisone [29], it was surprising that half as much proges-
terone (50 p.M) caused 50% inhibition of the 100 p.M hydrocorti-
sone effect (Table II) . The reasons for these discrepancies 
remain unknown at present. Since we used an intact skin 
(epidermal) slice system, t here would be other factors besides 
glucocorticoid receptor binding that would affect the expression 
of glucocorticoid effects, such as diffusion and metabolism of 
steroids. Thus our system might be relevant to in vivo findings; 
for example, th at clinically useful glucocorticoids attain a n 
epidermal concentration far greater than that needed to satu-
rate glucocorticoid receptors [37]. 
As was discussed by Voorhees et al [38], it has been ac knowl-
edged that glucocorticoids and cyclic AMP induce similar 
changes in epidermis (see also [11]). However, it has been 
suggested that these 2 compounds work independently and 
there was scanty evidence on their interactions. Our findings 
clearly indicate that glucocorticoids work on the cyclic AMP 
system th.rough regulation of the beta-adrenergic adenylate 
cyclase system, the most unstable receptor system in epidermis. 
Although this might not be the only effect of glucocorticoids on 
the epidermal cyclic AMP system, this effect of glucocorticoids 
might be significantly involved in physiologic and pharmaco-
logic effects of these compounds on epidermis, which might be 
related to the therapeutic effect of steroids on the pathologic 
conditions of the skin such as psoriatic-involved epidermis 
where the defective beta-adrenergic responsiveness has been 
noted repeatedly [10,39,40]. 
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